{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:20:01Z","timestamp":1790706001375,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}],"id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NV19-09-00578"],"award-info":[{"award-number":["NV19-09-00578"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018512","name":"Univerzita Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","award":["RVO 68378050"],"award-info":[{"award-number":["RVO 68378050"]}],"id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018512","name":"Univerzita Hradec Kr\u00e1lov\u00e9","doi-asserted-by":"publisher","award":["2108-2023"],"award-info":[{"award-number":["2108-2023"]}],"id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["APVV-19-0087"],"award-info":[{"award-number":["APVV-19-0087"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0482\/20"],"award-info":[{"award-number":["1\/0482\/20"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115600","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:10:19Z","timestamp":1696079419000},"page":"115600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Frentizole derivatives with mTOR inhibiting and senomorphic properties"],"prefix":"10.1016","volume":"167","author":[{"given":"Zofia","family":"Chrienova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rysanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9764-6195","authenticated-orcid":false,"given":"Josef","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-9929","authenticated-orcid":false,"given":"Pavla","family":"Vasicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-7671","authenticated-orcid":false,"given":"Patrik","family":"Oleksak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Andrys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-6857","authenticated-orcid":false,"given":"Adam","family":"Skarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8078-9878","authenticated-orcid":false,"given":"Jelena","family":"Dumanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Milovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5137-2638","authenticated-orcid":false,"given":"Vesna","family":"Jacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7630-7362","authenticated-orcid":false,"given":"Marketa","family":"Chvojkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-2737","authenticated-orcid":false,"given":"Kristina","family":"Holubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Vales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-8389","authenticated-orcid":false,"given":"Veronika","family":"Skoupilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Jomova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliman Y.","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda D.","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanos C.C.","family":"Franca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-6796","authenticated-orcid":false,"given":"Zdenek","family":"Hodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-246X","authenticated-orcid":false,"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib1","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/med.21702","article-title":"Emerging use of senolytics and senomorphics against aging and chronic diseases","volume":"40","author":"Martel","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115600_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tcb.2020.07.002","article-title":"A senescence-centric view of aging: implications for longevity and disease","volume":"30","author":"Borghesan","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Collado","year":"2007","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.biopha.2023.115600_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115600_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and alzheimer disease: the egg and the chicken scenario","volume":"21","author":"Saez-Atienzar","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115600_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: from physiology to pathology","volume":"15","author":"Mu\u00f1oz-Esp\u00edn","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115600_bib7","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.18632\/aging.101647","article-title":"Disease or not, aging is easily treatable","volume":"10","author":"Blagosklonny","year":"2018","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18632\/aging.100034","article-title":"Validation of anti-aging drugs by treating age-related diseases","volume":"1","author":"Blagosklonny","year":"2009","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2023.115600_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.520","article-title":"Koschei the immortal and anti-aging drugs","volume":"5","author":"Blagosklonny","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115600_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exger.2014.07.003","article-title":"What is an anti-aging treatment?","volume":"58","author":"Gems","year":"2014","journal-title":"Exp. Gerontol."},{"issue":"6483","key":"10.1016\/j.biopha.2023.115600_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by g1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2023.115600_bib12","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/14756366.2021.1955873","article-title":"The role of MTOR in age-related diseases","volume":"36","author":"Chrienova","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6967","key":"10.1016\/j.biopha.2023.115600_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"issue":"7253","key":"10.1016\/j.biopha.2023.115600_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the MTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.biopha.2023.115600_bib17","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4161\/cc.7.21.6965","article-title":"Aging: ROS or TOR","volume":"7","author":"Blagosklonny","year":"2008","journal-title":"Cell Cycle Georget. Tex."},{"issue":"1","key":"10.1016\/j.biopha.2023.115600_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/brv.12103","article-title":"The role of mitochondria in MTOR-regulated longevity","volume":"90","author":"Wei","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"4","key":"10.1016\/j.biopha.2023.115600_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10522-013-9435-6","article-title":"Growth or longevity: the TOR\u2019s decision on lifespan regulation","volume":"14","author":"Wei","year":"2013","journal-title":"Biogerontology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000484629","article-title":"MTOR as regulator of lifespan, aging, and cellular senescence: a mini-review","volume":"64","author":"Weichhart","year":"2018","journal-title":"Gerontology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib21","first-page":"75","article-title":"Signaling and damaging functions of free radicals in aging-free radical theory, hormesis, and TOR","volume":"1","author":"Afanas\u2019ev","year":"2010","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115600_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ijms23010077","article-title":"Inflammation, oxidative stress, senescence in atherosclerosis: thioredoxine-1 as an emerging therapeutic target","volume":"23","author":"El Hadri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0959-9673.2005.00427.x","article-title":"Mitochondrial dysfunction and Alzheimer\u2019s disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD)","volume":"86","author":"Yan","year":"2005","journal-title":"Int. J. Exp. Pathol."},{"issue":"10A","key":"10.1016\/j.biopha.2023.115600_bib25","article-title":"Why have antioxidants failed in clinical trials?","volume":"101","author":"Steinhubl","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.115600_bib26","doi-asserted-by":"crossref","unstructured":"Walker, S.E.; Solsky, M.; Schnitzer, B. Prolonged lifespans in female NZB\/NZW mice treated with the experimental immunoregulatory drug frentizole. Arthritis and rheumatism. \u3008https:\/\/doi.org\/10.1002\/art.1780251104\u3009.","DOI":"10.1002\/art.1780251104"},{"key":"10.1016\/j.biopha.2023.115600_bib27","doi-asserted-by":"crossref","unstructured":"Hatfield, S.M.; Hartley, L.W.; Schmidtke, J.R. The immunomodulatory action of frentizole, a novel immunosuppressive agent. Immunopharmacology. \u3008https:\/\/doi.org\/10.1016\/0162\u20133109(82)90047\u20139\u3009.","DOI":"10.1016\/0162-3109(82)90047-9"},{"key":"10.1016\/j.biopha.2023.115600_bib28","doi-asserted-by":"crossref","unstructured":"Scheetz, M.E.; Carlson, D.G.; Schinitsky, M.R. Frentizole, a novel immunosuppressive, and azathioprine: their comparative effects on host resistance to Pseudomonas aeruginosa, Candida albicans, herpes simplex virus, and influenza (Ann Arbor) virus. Infection and immunity. \u3008https:\/\/doi.org\/10.1128\/iai.15.1.145\u2013148.1977\u3009.","DOI":"10.1128\/iai.15.1.145-148.1977"},{"key":"10.1016\/j.biopha.2023.115600_bib29","doi-asserted-by":"crossref","unstructured":"Xie, Y.; Deng, S.; Chen, Z.; Yan, S.; Landry, L. Identification of small-molecule inhibitors of the Abeta-ABAD interaction. Bioorganic & medicinal chemistry letters. \u3008https:\/\/doi.org\/10.1016\/j.bmcl.2006.05.099\u3009.","DOI":"10.1016\/j.bmcl.2006.05.099"},{"issue":"15","key":"10.1016\/j.biopha.2023.115600_bib30","article-title":"Novel benzothiazole-based ureas as 17\u03b2-HSD10 inhibitors, a potential Alzheimer\u2019s disease treatment","volume":"24","author":"Aitken","year":"2019","journal-title":"Mol. Basel Switz."},{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062059","article-title":"Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17\u03b2-HSD10 with Implications to Alzheimer\u2019s disease treatment","volume":"21","author":"Schmidt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2023.115600_bib32","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/j.bmcl.2016.05.087","article-title":"Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD\/17\u03b2-HSD10 modulators for Alzheimer\u2019s disease treatment","volume":"26","author":"Hroch","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bmc.2016.12.029","article-title":"Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO\/ABAD inhibitors for Alzheimer\u2019s disease treatment","volume":"25","author":"Hroch","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115600_bib34","article-title":"6-benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD\/17\u03b2-HSD10 and potential drugs for Alzheimer\u2019s disease treatment: design, synthesis and in vitro evaluation","author":"Benek","year":"2017","journal-title":"Med. Chem. Shariqah U. Arab Emir."},{"issue":"1","key":"10.1016\/j.biopha.2023.115600_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14756366.2018.1445736","article-title":"1-(Benzo[d]Thiazol-2-Yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders","volume":"33","author":"Benek","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2023.115600_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-022-05309-2","article-title":"Virtual screening and molecular dynamic study of potential new binders to MTOR","volume":"28","author":"Botelho","year":"2022","journal-title":"J. Mol. Model."},{"issue":"11","key":"10.1016\/j.biopha.2023.115600_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/13543776.2021.1940137","article-title":"A patent review of MTOR inhibitors for cancer therapy (2011-2020)","volume":"31","author":"Qiu","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2023.115600_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114498","article-title":"Contemporary MTOR inhibitor scaffolds to diseases breakdown: a patent review (2015-2021)","volume":"238","author":"Oleksak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.biopha.2023.115600_bib39","first-page":"5295","article-title":"Overview of research into MTOR inhibitors","volume":"27","author":"Mao","year":"2022","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.biopha.2023.115600_bib40","doi-asserted-by":"crossref","unstructured":"Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings1PII of Original Article: S0169\u2013409X(96)00423\u20131. The Article Was Originally Published in Advanced Drug Delivery Reviews 23 (1997) 3\u201325.1. Adv. Drug Deliv. Rev. 2001, 46 (1), 3\u201326. https:\/\/doi.org\/10.1016\/S0169\u2013409X(00)00129\u20130.","DOI":"10.1016\/S0169-409X(00)00129-0"},{"issue":"12","key":"10.1016\/j.biopha.2023.115600_bib41","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2023.115600_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045069","article-title":"Astrocyte senescence as a component of Alzheimer\u2019s disease","volume":"7","author":"Bhat","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.biopha.2023.115600_bib43","article-title":"Profiling senescent cells in human brains reveals neurons with CDKN2D\/P19 and tau neuropathology","volume":"1","author":"Sk","year":"2021","journal-title":"Nat. Aging"},{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib44","article-title":"Emerging anti-aging strategies - scientific basis and efficacy","volume":"9","author":"Ak","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2023.115600_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","article-title":"Senescence and senotherapeutics: a new field in cancer therapy","volume":"193","author":"Myrianthopoulos","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115600_bib46","first-page":"1997","article-title":"Distinct phenotypes and \u201cbystander\u201d effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines","volume":"53","author":"Sapega","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115600_bib47","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","article-title":"MTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype","volume":"17","author":"Herranz","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115600_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115600_bib49","article-title":"MCP-1 targeting: shutting off an engine for tumor development","volume":"23","author":"Wang","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2023.115600_bib50","first-page":"7","article-title":"[Visual development in the child. The stages]","volume":"No. 120","author":"Epelbaum","year":"1991","journal-title":"Soins. Gynecol. Obstet. Pueric. Pediatr."},{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib51","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"MTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2023.115600_bib52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2023.115600_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111428","article-title":"Effects of cellular senescence on metabolic pathways in non-immune and immune cells","volume":"194","author":"Frasca","year":"2021","journal-title":"Mech. Ageing Dev."},{"issue":"6","key":"10.1016\/j.biopha.2023.115600_bib54","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-03-0502","article-title":"Rapamycin-Induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer","volume":"10","author":"Bruns","year":"2004","journal-title":"Clin. Cancer Res. . J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/acel.12587","article-title":"Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism","volume":"16","author":"Wang","year":"2017","journal-title":"Aging Cell"},{"issue":"17","key":"10.1016\/j.biopha.2023.115600_bib56","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.7150\/ijms.40159","article-title":"Mitochondrial dysfunction contributes to rapamycin-induced apoptosis of human glioblastoma cells - a synergistic effect with temozolomide","volume":"17","author":"Zimmerman","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bjc.6600711","article-title":"Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids","volume":"88","author":"G\u00fcnther","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib58","first-page":"2477","article-title":"Effect and molecular mechanism of MTOR inhibitor rapamycin on temozolomide-induced autophagic death of U251 glioma cells","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.115600_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728222.2016.1151002","article-title":"MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance","volume":"20","author":"Garros-Regulez","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2023.115600_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37837-4","article-title":"Toxic injury to muscle tissue of rats following acute oximes exposure","volume":"9","author":"Jacevic","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115600_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cbi.2019.05.035","article-title":"Interspecies and intergender differences in acute toxicity of K-oximes drug candidates","volume":"308","author":"Jacevic","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2023.115600_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1048260","article-title":"Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics","volume":"14","author":"Chrienova","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"16","key":"10.1016\/j.biopha.2023.115600_bib63","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.18632\/aging.204207","article-title":"Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells","volume":"14","author":"Rysanek","year":"2022","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/onc.2009.318","article-title":"Cytokine expression and signaling in drug-induced cellular senescence","volume":"29","author":"Novakova","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2023.115600_bib65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4161\/cc.10.3.14707","article-title":"Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of P16(Ink4a)","volume":"10","author":"Kosar","year":"2011","journal-title":"Cell Cycle Georget. Tex."},{"issue":"4","key":"10.1016\/j.biopha.2023.115600_bib66","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal violet assay for determining viability of cultured cells","volume":"2016","author":"Feoktistova","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"issue":"7","key":"10.1016\/j.biopha.2023.115600_bib67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.biopha.2023.115600_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.biopha.2023.115600_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2025.117883","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:23:59Z","timestamp":1776461039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":69,"alternative-id":["S0753332223013987"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115600","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frentizole derivatives with mTOR inhibiting and senomorphic properties","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115600"}}